#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=5. Adipose Tissue Inflammation during Aging
1-1	0-2	5.	_	_	_	_
1-2	3-10	Adipose	abstract|object[2]|abstract[3]	new|new[2]|new[3]	coref|coref|coref	2-1|2-1[5_2]|2-15[9_3]
1-3	11-17	Tissue	object[2]|abstract[3]	new[2]|new[3]	_	_
1-4	18-30	Inflammation	abstract[3]	new[3]	_	_
1-5	31-37	during	_	_	_	_
1-6	38-43	Aging	_	_	_	_

#Text=Adipose tissue plays an essential role in age-related metabolic dysfunction and is linked to systemic , chronic , and low-grade inflammation .
2-1	44-51	Adipose	abstract|object[5]	giv|giv[5]	coref|coref	4-1|4-2[0_5]
2-2	52-58	tissue	object[5]	giv[5]	_	_
2-3	59-64	plays	_	_	_	_
2-4	65-67	an	abstract[6]	new[6]	_	_
2-5	68-77	essential	abstract[6]	new[6]	_	_
2-6	78-82	role	abstract[6]	new[6]	_	_
2-7	83-85	in	abstract[6]	new[6]	_	_
2-8	86-97	age-related	abstract[6]|abstract[8]	new[6]|new[8]	coref	10-12[98_8]
2-9	98-107	metabolic	abstract[6]|abstract|abstract[8]	new[6]|new|new[8]	_	_
2-10	108-119	dysfunction	abstract[6]|abstract[8]	new[6]|new[8]	_	_
2-11	120-123	and	_	_	_	_
2-12	124-126	is	_	_	_	_
2-13	127-133	linked	_	_	_	_
2-14	134-136	to	_	_	_	_
2-15	137-145	systemic	abstract[9]	giv[9]	coref	3-18[13_9]
2-16	146-147	,	abstract[9]	giv[9]	_	_
2-17	148-155	chronic	abstract[9]	giv[9]	_	_
2-18	156-157	,	abstract[9]	giv[9]	_	_
2-19	158-161	and	abstract[9]	giv[9]	_	_
2-20	162-171	low-grade	abstract[9]	giv[9]	_	_
2-21	172-184	inflammation	abstract[9]	giv[9]	_	_
2-22	185-186	.	_	_	_	_

#Text=Aging is associated with a decline in immune competence referred to as immunosenescence , which leads to chronic , low-grade inflammation named “ inflammaging ” .
3-1	187-192	Aging	_	_	_	_
3-2	193-195	is	_	_	_	_
3-3	196-206	associated	_	_	_	_
3-4	207-211	with	_	_	_	_
3-5	212-213	a	abstract[10]	new[10]	_	_
3-6	214-221	decline	abstract[10]	new[10]	_	_
3-7	222-224	in	abstract[10]	new[10]	_	_
3-8	225-231	immune	abstract[10]|abstract[11]	new[10]|new[11]	_	_
3-9	232-242	competence	abstract[10]|abstract[11]	new[10]|new[11]	_	_
3-10	243-251	referred	_	_	_	_
3-11	252-254	to	_	_	_	_
3-12	255-257	as	_	_	_	_
3-13	258-274	immunosenescence	abstract	new	coref	4-47
3-14	275-276	,	_	_	_	_
3-15	277-282	which	_	_	_	_
3-16	283-288	leads	_	_	_	_
3-17	289-291	to	_	_	_	_
3-18	292-299	chronic	abstract[13]	giv[13]	coref	4-3[0_13]
3-19	300-301	,	abstract[13]	giv[13]	_	_
3-20	302-311	low-grade	abstract[13]	giv[13]	_	_
3-21	312-324	inflammation	abstract[13]	giv[13]	_	_
3-22	325-330	named	_	_	_	_
3-23	331-332	“	_	_	_	_
3-24	333-345	inflammaging	plant	new	_	_
3-25	346-347	”	_	_	_	_
3-26	348-349	.	_	_	_	_

#Text=Adipose tissue inflammation results in the release of pro-inflammatory cytokines such as TNF-α , IL-1b , IL-6 and monocyte chemoattractant protein ( MCP-1/CCL2 ) from adipose tissue macrophages , and these factors are also associated to the presence of senescent cells ( p16INK4A ) leading to immunosenescence .
4-1	350-357	Adipose	abstract|abstract[18]	giv|new[18]	coref	4-26
4-2	358-364	tissue	object|abstract[18]	giv|new[18]	coref	4-27
4-3	365-377	inflammation	abstract|abstract[18]	giv|new[18]	coref	5-24[46_0]
4-4	378-385	results	abstract[18]	new[18]	_	_
4-5	386-388	in	abstract[18]	new[18]	_	_
4-6	389-392	the	abstract[18]|event[19]	new[18]|new[19]	_	_
4-7	393-400	release	abstract[18]|event[19]	new[18]|new[19]	_	_
4-8	401-403	of	abstract[18]|event[19]	new[18]|new[19]	_	_
4-9	404-420	pro-inflammatory	abstract[18]|event[19]|abstract[20]	new[18]|new[19]|new[20]	coref	5-8[0_20]
4-10	421-430	cytokines	abstract[18]|event[19]|abstract[20]	new[18]|new[19]|new[20]	_	_
4-11	431-435	such	abstract[18]|event[19]	new[18]|new[19]	_	_
4-12	436-438	as	abstract[18]|event[19]	new[18]|new[19]	_	_
4-13	439-444	TNF-α	abstract[18]|event[19]|event|abstract[22]	new[18]|new[19]|new|new[22]	coref|coref	7-31|13-28[133_22]
4-14	445-446	,	abstract[18]|event[19]|abstract[22]	new[18]|new[19]|new[22]	_	_
4-15	447-452	IL-1b	abstract[18]|event[19]|abstract[22]|event	new[18]|new[19]|new[22]|new	_	_
4-16	453-454	,	abstract[18]|event[19]|abstract[22]	new[18]|new[19]|new[22]	_	_
4-17	455-459	IL-6	abstract[18]|event[19]|abstract[22]|event	new[18]|new[19]|new[22]|new	coref	7-26
4-18	460-463	and	abstract[18]|event[19]|abstract[22]	new[18]|new[19]|new[22]	_	_
4-19	464-472	monocyte	abstract[18]|event[19]|abstract[22]|substance[26]	new[18]|new[19]|new[22]|new[26]	coref	16-19[0_26]
4-20	473-488	chemoattractant	abstract[18]|event[19]|abstract[22]|object|substance[26]	new[18]|new[19]|new[22]|new|new[26]	_	_
4-21	489-496	protein	abstract[18]|event[19]|abstract[22]|substance[26]	new[18]|new[19]|new[22]|new[26]	_	_
4-22	497-498	(	_	_	_	_
4-23	499-509	MCP-1/CCL2	object	new	_	_
4-24	510-511	)	_	_	_	_
4-25	512-516	from	_	_	_	_
4-26	517-524	adipose	abstract|object[30]	giv|new[30]	coref|coref	5-4[37_30]|5-18
4-27	525-531	tissue	object|object[30]	giv|new[30]	coref	5-17[43_0]
4-28	532-543	macrophages	object[30]	new[30]	_	_
4-29	544-545	,	_	_	_	_
4-30	546-549	and	_	_	_	_
4-31	550-555	these	abstract[31]	new[31]	coref	16-34[178_31]
4-32	556-563	factors	abstract[31]	new[31]	_	_
4-33	564-567	are	_	_	_	_
4-34	568-572	also	_	_	_	_
4-35	573-583	associated	_	_	_	_
4-36	584-586	to	_	_	_	_
4-37	587-590	the	abstract[32]	new[32]	_	_
4-38	591-599	presence	abstract[32]	new[32]	_	_
4-39	600-602	of	abstract[32]	new[32]	_	_
4-40	603-612	senescent	abstract[32]|object[33]	new[32]|new[33]	appos	4-43[0_33]
4-41	613-618	cells	abstract[32]|object[33]	new[32]|new[33]	_	_
4-42	619-620	(	_	_	_	_
4-43	621-629	p16INK4A	object	giv	coref	11-16[105_0]
4-44	630-631	)	_	_	_	_
4-45	632-639	leading	_	_	_	_
4-46	640-642	to	_	_	_	_
4-47	643-659	immunosenescence	abstract	giv	coref	11-9
4-48	660-661	.	_	_	_	_

#Text=The exposure of macrophages to hormones , cytokines , chemokines , and fatty acids found within dysfunctional adipose tissue stimulates them to adopt a pro-inflammatory phenotype inflammation .
5-1	662-665	The	abstract[36]	new[36]	_	_
5-2	666-674	exposure	abstract[36]	new[36]	_	_
5-3	675-677	of	abstract[36]	new[36]	_	_
5-4	678-689	macrophages	abstract[36]|object[37]	new[36]|giv[37]	coref	6-22[57_37]
5-5	690-692	to	abstract[36]|object[37]	new[36]|giv[37]	_	_
5-6	693-701	hormones	abstract[36]|object[37]|substance	new[36]|giv[37]|new	_	_
5-7	702-703	,	abstract[36]|object[37]	new[36]|giv[37]	_	_
5-8	704-713	cytokines	abstract[36]|object[37]|abstract	new[36]|giv[37]|giv	coref	7-31[72_0]
5-9	714-715	,	abstract[36]|object[37]	new[36]|giv[37]	_	_
5-10	716-726	chemokines	abstract[36]|object[37]|substance	new[36]|giv[37]|new	_	_
5-11	727-728	,	abstract[36]|object[37]	new[36]|giv[37]	_	_
5-12	729-732	and	abstract[36]|object[37]	new[36]|giv[37]	_	_
5-13	733-738	fatty	abstract[36]|object[37]|substance[41]	new[36]|giv[37]|new[41]	ana	5-21[0_41]
5-14	739-744	acids	abstract[36]|object[37]|substance[41]	new[36]|giv[37]|new[41]	_	_
5-15	745-750	found	_	_	_	_
5-16	751-757	within	_	_	_	_
5-17	758-771	dysfunctional	object[43]	giv[43]	coref	6-3[0_43]
5-18	772-779	adipose	abstract|object[43]	giv|giv[43]	coref	6-2
5-19	780-786	tissue	object[43]	giv[43]	_	_
5-20	787-797	stimulates	_	_	_	_
5-21	798-802	them	substance	giv	_	_
5-22	803-805	to	_	_	_	_
5-23	806-811	adopt	_	_	_	_
5-24	812-813	a	abstract[46]	giv[46]	coref	6-1[49_46]
5-25	814-830	pro-inflammatory	abstract[46]	giv[46]	_	_
5-26	831-840	phenotype	abstract|abstract[46]	new|giv[46]	_	_
5-27	841-853	inflammation	abstract[46]	giv[46]	_	_
5-28	854-855	.	_	_	_	_

#Text=Age-associated adipose tissue inflammation is related to the activation of the NFκB signaling pathway , with promotes a pro-inflammatory polarization of adipose tissue macrophages , independent from total adipose tissue mass .
6-1	856-870	Age-associated	abstract[49]	giv[49]	coref	15-29[158_49]
6-2	871-878	adipose	abstract|abstract[49]	giv|giv[49]	coref	6-22
6-3	879-885	tissue	object|abstract[49]	giv|giv[49]	coref	6-23
6-4	886-898	inflammation	abstract[49]	giv[49]	_	_
6-5	899-901	is	_	_	_	_
6-6	902-909	related	_	_	_	_
6-7	910-912	to	_	_	_	_
6-8	913-916	the	abstract[50]	new[50]	coref	11-12[0_50]
6-9	917-927	activation	abstract[50]	new[50]	_	_
6-10	928-930	of	abstract[50]	new[50]	_	_
6-11	931-934	the	abstract[50]|abstract[53]	new[50]|new[53]	_	_
6-12	935-939	NFκB	abstract[50]|abstract|abstract[53]	new[50]|new|new[53]	coref	13-43
6-13	940-949	signaling	abstract[50]|abstract|abstract[53]	new[50]|new|new[53]	coref	9-29[89_0]
6-14	950-957	pathway	abstract[50]|abstract[53]	new[50]|new[53]	_	_
6-15	958-959	,	_	_	_	_
6-16	960-964	with	_	_	_	_
6-17	965-973	promotes	_	_	_	_
6-18	974-975	a	abstract[54]	new[54]	coref	7-4[63_54]
6-19	976-992	pro-inflammatory	abstract[54]	new[54]	_	_
6-20	993-1005	polarization	abstract[54]	new[54]	_	_
6-21	1006-1008	of	abstract[54]	new[54]	_	_
6-22	1009-1016	adipose	abstract[54]|abstract|object[57]	new[54]|giv|giv[57]	coref|coref	6-29|11-2[0_57]
6-23	1017-1023	tissue	abstract[54]|object|object[57]	new[54]|giv|giv[57]	coref	6-30
6-24	1024-1035	macrophages	abstract[54]|object[57]	new[54]|giv[57]	_	_
6-25	1036-1037	,	_	_	_	_
6-26	1038-1049	independent	_	_	_	_
6-27	1050-1054	from	_	_	_	_
6-28	1055-1060	total	quantity[60]	new[60]	_	_
6-29	1061-1068	adipose	abstract|quantity[60]	giv|new[60]	coref	7-34
6-30	1069-1075	tissue	object|quantity[60]	giv|new[60]	coref	7-34[74_0]
6-31	1076-1080	mass	quantity[60]	new[60]	_	_
6-32	1081-1082	.	_	_	_	_

#Text=The stimulus for age-associated macrophage pro-inflammatory polarization can be associated with endoplasmic reticulum stress , which promotes a pro-inflammatory environment due to the release of IL-6 , MCP-1 , and TNF-α cytokines within adipose tissue .
7-1	1083-1086	The	abstract[61]	new[61]	_	_
7-2	1087-1095	stimulus	abstract[61]	new[61]	_	_
7-3	1096-1099	for	abstract[61]	new[61]	_	_
7-4	1100-1114	age-associated	abstract[61]|abstract[63]	new[61]|giv[63]	_	_
7-5	1115-1125	macrophage	abstract[61]|place|abstract[63]	new[61]|new|giv[63]	coref	8-14
7-6	1126-1142	pro-inflammatory	abstract[61]|abstract[63]	new[61]|giv[63]	_	_
7-7	1143-1155	polarization	abstract[61]|abstract[63]	new[61]|giv[63]	_	_
7-8	1156-1159	can	_	_	_	_
7-9	1160-1162	be	_	_	_	_
7-10	1163-1173	associated	_	_	_	_
7-11	1174-1178	with	_	_	_	_
7-12	1179-1190	endoplasmic	abstract|abstract[66]	new|new[66]	coref	10-6[0_66]
7-13	1191-1200	reticulum	abstract|abstract[66]	new|new[66]	_	_
7-14	1201-1207	stress	abstract[66]	new[66]	_	_
7-15	1208-1209	,	_	_	_	_
7-16	1210-1215	which	_	_	_	_
7-17	1216-1224	promotes	_	_	_	_
7-18	1225-1226	a	abstract[67]	new[67]	coref	15-4[149_67]
7-19	1227-1243	pro-inflammatory	abstract[67]	new[67]	_	_
7-20	1244-1255	environment	abstract[67]	new[67]	_	_
7-21	1256-1259	due	_	_	_	_
7-22	1260-1262	to	_	_	_	_
7-23	1263-1266	the	event[68]	new[68]	coref	12-6[119_68]
7-24	1267-1274	release	event[68]	new[68]	_	_
7-25	1275-1277	of	event[68]	new[68]	_	_
7-26	1278-1282	IL-6	event[68]|abstract	new[68]|giv	coref	13-32
7-27	1283-1284	,	event[68]	new[68]	_	_
7-28	1285-1290	MCP-1	event[68]|substance	new[68]|new	_	_
7-29	1291-1292	,	event[68]	new[68]	_	_
7-30	1293-1296	and	event[68]	new[68]	_	_
7-31	1297-1302	TNF-α	event[68]|abstract|abstract[72]	new[68]|giv|giv[72]	coref	13-28
7-32	1303-1312	cytokines	event[68]|abstract[72]	new[68]|giv[72]	_	_
7-33	1313-1319	within	event[68]|abstract[72]	new[68]|giv[72]	_	_
7-34	1320-1327	adipose	event[68]|abstract[72]|abstract|object[74]	new[68]|giv[72]|giv|giv[74]	coref|coref	8-12|8-13[0_74]
7-35	1328-1334	tissue	event[68]|abstract[72]|object[74]	new[68]|giv[72]|giv[74]	_	_
7-36	1335-1336	.	_	_	_	_

#Text=The decreased vascularization promoted by aging promotes local hypoxia and favors adipose tissue macrophage accumulation .
8-1	1337-1340	The	abstract[75]	new[75]	_	_
8-2	1341-1350	decreased	abstract[75]	new[75]	_	_
8-3	1351-1366	vascularization	abstract[75]	new[75]	_	_
8-4	1367-1375	promoted	_	_	_	_
8-5	1376-1378	by	_	_	_	_
8-6	1379-1384	aging	abstract	new	coref	15-10
8-7	1385-1393	promotes	_	_	_	_
8-8	1394-1399	local	abstract[77]	new[77]	_	_
8-9	1400-1407	hypoxia	abstract[77]	new[77]	_	_
8-10	1408-1411	and	_	_	_	_
8-11	1412-1418	favors	_	_	_	_
8-12	1419-1426	adipose	abstract|abstract[81]	giv|new[81]	coref|coref	11-5|12-1[116_81]
8-13	1427-1433	tissue	object|abstract[81]	giv|new[81]	coref	11-4[101_0]
8-14	1434-1444	macrophage	place|abstract[81]	giv|new[81]	_	_
8-15	1445-1457	accumulation	abstract[81]	new[81]	_	_
8-16	1458-1459	.	_	_	_	_

#Text=The macrophage infiltration is perpetuated by a reduction in the mitochondrial cytochrome c oxidase subunit 5B ( COX5B ) component of complex IV within adipocytes , which inhibits lipolytic signaling and free-fatty acid mobilization and increases intracellular lipid storage .
9-1	1460-1463	The	event[82]	new[82]	_	_
9-2	1464-1474	macrophage	event[82]	new[82]	_	_
9-3	1475-1487	infiltration	event[82]	new[82]	_	_
9-4	1488-1490	is	_	_	_	_
9-5	1491-1502	perpetuated	_	_	_	_
9-6	1503-1505	by	_	_	_	_
9-7	1506-1507	a	abstract[83]	new[83]	_	_
9-8	1508-1517	reduction	abstract[83]	new[83]	_	_
9-9	1518-1520	in	abstract[83]	new[83]	_	_
9-10	1521-1524	the	abstract[83]|abstract[84]	new[83]|new[84]	_	_
9-11	1525-1538	mitochondrial	abstract[83]|abstract[84]	new[83]|new[84]	_	_
9-12	1539-1549	cytochrome	abstract[83]|abstract[84]	new[83]|new[84]	_	_
9-13	1550-1551	c	abstract[83]|abstract[84]	new[83]|new[84]	_	_
9-14	1552-1559	oxidase	_	_	_	_
9-15	1560-1567	subunit	_	_	_	_
9-16	1568-1570	5B	_	_	_	_
9-17	1571-1572	(	_	_	_	_
9-18	1573-1578	COX5B	object	new	_	_
9-19	1579-1580	)	_	_	_	_
9-20	1581-1590	component	abstract[86]	new[86]	_	_
9-21	1591-1593	of	abstract[86]	new[86]	_	_
9-22	1594-1601	complex	abstract[86]|abstract[87]	new[86]|new[87]	_	_
9-23	1602-1604	IV	abstract[86]|abstract[87]	new[86]|new[87]	_	_
9-24	1605-1611	within	abstract[86]|abstract[87]	new[86]|new[87]	_	_
9-25	1612-1622	adipocytes	abstract[86]|abstract[87]|object	new[86]|new[87]|new	coref	10-4
9-26	1623-1624	,	_	_	_	_
9-27	1625-1630	which	_	_	_	_
9-28	1631-1639	inhibits	_	_	_	_
9-29	1640-1649	lipolytic	abstract[89]	giv[89]	_	_
9-30	1650-1659	signaling	abstract[89]	giv[89]	_	_
9-31	1660-1663	and	_	_	_	_
9-32	1664-1674	free-fatty	event[91]	new[91]	_	_
9-33	1675-1679	acid	substance|event[91]	new|new[91]	_	_
9-34	1680-1692	mobilization	event[91]	new[91]	_	_
9-35	1693-1696	and	_	_	_	_
9-36	1697-1706	increases	_	_	_	_
9-37	1707-1720	intracellular	abstract[93]	new[93]	_	_
9-38	1721-1726	lipid	abstract|abstract[93]	new|new[93]	_	_
9-39	1727-1734	storage	abstract[93]	new[93]	_	_
9-40	1735-1736	.	_	_	_	_

#Text=Hypertrophic expansion of adipocytes promotes stress signals , thereby contributing to immunometabolic dysfunction both locally and systemically .
10-1	1737-1749	Hypertrophic	abstract[94]	new[94]	_	_
10-2	1750-1759	expansion	abstract[94]	new[94]	_	_
10-3	1760-1762	of	abstract[94]	new[94]	_	_
10-4	1763-1773	adipocytes	abstract[94]|object	new[94]|giv	coref	15-46
10-5	1774-1782	promotes	_	_	_	_
10-6	1783-1789	stress	abstract|abstract[97]	giv|new[97]	_	_
10-7	1790-1797	signals	abstract[97]	new[97]	_	_
10-8	1798-1799	,	_	_	_	_
10-9	1800-1807	thereby	_	_	_	_
10-10	1808-1820	contributing	_	_	_	_
10-11	1821-1823	to	_	_	_	_
10-12	1824-1839	immunometabolic	abstract[98]	giv[98]	coref	15-17[154_98]
10-13	1840-1851	dysfunction	abstract[98]	giv[98]	_	_
10-14	1852-1856	both	_	_	_	_
10-15	1857-1864	locally	_	_	_	_
10-16	1865-1868	and	_	_	_	_
10-17	1869-1881	systemically	_	_	_	_
10-18	1882-1883	.	_	_	_	_

#Text=Besides macrophages , dysfunctional adipose tissue can exacerbate immunosenescence by promoting activation and differentiation of immune cells such as B cells ( B lymphocytes ) , nautral killer ( NK ) lymphocytes , regulatory T cells , neutrophils , eosinophils , mast cells , dendritic cells .
11-1	1884-1891	Besides	_	_	_	_
11-2	1892-1903	macrophages	object	giv	_	_
11-3	1904-1905	,	_	_	_	_
11-4	1906-1919	dysfunctional	object[101]	giv[101]	coref	13-21[131_101]
11-5	1920-1927	adipose	abstract|object[101]	giv|giv[101]	coref	13-23
11-6	1928-1934	tissue	object[101]	giv[101]	_	_
11-7	1935-1938	can	_	_	_	_
11-8	1939-1949	exacerbate	_	_	_	_
11-9	1950-1966	immunosenescence	abstract	giv	_	_
11-10	1967-1969	by	_	_	_	_
11-11	1970-1979	promoting	_	_	_	_
11-12	1980-1990	activation	abstract	giv	coref	12-12[121_0]
11-13	1991-1994	and	_	_	_	_
11-14	1995-2010	differentiation	abstract[104]	new[104]	coref	15-35[161_104]
11-15	2011-2013	of	abstract[104]	new[104]	_	_
11-16	2014-2020	immune	abstract[104]|object[105]	new[104]|giv[105]	coref	11-20[106_105]
11-17	2021-2026	cells	abstract[104]|object[105]	new[104]|giv[105]	_	_
11-18	2027-2031	such	abstract[104]	new[104]	_	_
11-19	2032-2034	as	abstract[104]	new[104]	_	_
11-20	2035-2036	B	abstract[104]|object[106]	new[104]|giv[106]	appos	11-23[108_106]
11-21	2037-2042	cells	abstract[104]|object[106]	new[104]|giv[106]	_	_
11-22	2043-2044	(	_	_	_	_
11-23	2045-2046	B	place|object[108]	new|giv[108]	coref	11-32[111_108]
11-24	2047-2058	lymphocytes	object[108]	giv[108]	_	_
11-25	2059-2060	)	_	_	_	_
11-26	2061-2062	,	_	_	_	_
11-27	2063-2070	nautral	abstract[109]	new[109]	appos	11-30[0_109]
11-28	2071-2077	killer	abstract[109]	new[109]	_	_
11-29	2078-2079	(	_	_	_	_
11-30	2080-2082	NK	abstract	giv	coref	14-12
11-31	2083-2084	)	_	_	_	_
11-32	2085-2096	lymphocytes	object[111]	giv[111]	coref	13-4[125_111]
11-33	2097-2098	,	object[111]	giv[111]	_	_
11-34	2099-2109	regulatory	object[111]	giv[111]	_	_
11-35	2110-2111	T	object[111]|person	giv[111]|new	coref	14-9
11-36	2112-2117	cells	object[111]	giv[111]	_	_
11-37	2118-2119	,	object[111]	giv[111]	_	_
11-38	2120-2131	neutrophils	object[111]|abstract	giv[111]|new	coref	13-54
11-39	2132-2133	,	object[111]	giv[111]	_	_
11-40	2134-2145	eosinophils	object[111]|abstract	giv[111]|new	_	_
11-41	2146-2147	,	object[111]	giv[111]	_	_
11-42	2148-2152	mast	object[111]	giv[111]	_	_
11-43	2153-2158	cells	object[111]	giv[111]	_	_
11-44	2159-2160	,	object[111]	giv[111]	_	_
11-45	2161-2170	dendritic	object[111]	giv[111]	_	_
11-46	2171-2176	cells	object[111]	giv[111]	_	_
11-47	2177-2178	.	_	_	_	_

#Text=Immune cell accumulation in AT induces pro-inflammatory cytokine release leads to inflammasome activation and formation of crown-like structure .
12-1	2179-2185	Immune	abstract[116]	giv[116]	_	_
12-2	2186-2190	cell	place|abstract[116]	new|giv[116]	coref	13-48
12-3	2191-2203	accumulation	abstract[116]	giv[116]	_	_
12-4	2204-2206	in	abstract[116]	giv[116]	_	_
12-5	2207-2209	AT	abstract[116]	giv[116]	_	_
12-6	2210-2217	induces	abstract[116]|abstract|event[119]	giv[116]|new|giv[119]	coref	13-39[0_119]
12-7	2218-2234	pro-inflammatory	abstract[116]|event[119]	giv[116]|giv[119]	_	_
12-8	2235-2243	cytokine	abstract[116]|abstract|event[119]	giv[116]|new|giv[119]	_	_
12-9	2244-2251	release	abstract[116]|event[119]	giv[116]|giv[119]	_	_
12-10	2252-2257	leads	_	_	_	_
12-11	2258-2260	to	_	_	_	_
12-12	2261-2273	inflammasome	abstract|abstract[121]	new|giv[121]	coref	13-43[140_121]
12-13	2274-2284	activation	abstract[121]	giv[121]	_	_
12-14	2285-2288	and	_	_	_	_
12-15	2289-2298	formation	event[122]	new[122]	_	_
12-16	2299-2301	of	event[122]	new[122]	_	_
12-17	2302-2312	crown-like	event[122]|abstract[123]	new[122]|new[123]	_	_
12-18	2313-2322	structure	event[122]|abstract[123]	new[122]|new[123]	_	_
12-19	2323-2324	.	_	_	_	_

#Text=The function of immune cells have been investigated in obesity , however some studies suggest that the pro-inflammatory microenvironment of aged murine adipose tissue , characterized by TNF-α , IFN-γ , IL-6 and prostaglandin E2 ( PGE2 ) release , could promote NFκB activation consequently modulate dendritic cell function , also can activate neutrophils .
13-1	2325-2328	The	abstract[124]	new[124]	coref	13-47[142_124]
13-2	2329-2337	function	abstract[124]	new[124]	_	_
13-3	2338-2340	of	abstract[124]	new[124]	_	_
13-4	2341-2347	immune	abstract[124]|object[125]	new[124]|giv[125]	coref	14-8[146_125]
13-5	2348-2353	cells	abstract[124]|object[125]	new[124]|giv[125]	_	_
13-6	2354-2358	have	_	_	_	_
13-7	2359-2363	been	_	_	_	_
13-8	2364-2376	investigated	_	_	_	_
13-9	2377-2379	in	_	_	_	_
13-10	2380-2387	obesity	abstract	new	_	_
13-11	2388-2389	,	_	_	_	_
13-12	2390-2397	however	_	_	_	_
13-13	2398-2402	some	abstract[127]	new[127]	_	_
13-14	2403-2410	studies	abstract[127]	new[127]	_	_
13-15	2411-2418	suggest	_	_	_	_
13-16	2419-2423	that	_	_	_	_
13-17	2424-2427	the	abstract[128]	new[128]	_	_
13-18	2428-2444	pro-inflammatory	abstract[128]	new[128]	_	_
13-19	2445-2461	microenvironment	abstract[128]	new[128]	_	_
13-20	2462-2464	of	abstract[128]	new[128]	_	_
13-21	2465-2469	aged	abstract[128]|object[131]	new[128]|giv[131]	coref	15-14[152_131]
13-22	2470-2476	murine	abstract[128]|abstract|object[131]	new[128]|new|giv[131]	_	_
13-23	2477-2484	adipose	abstract[128]|abstract|object[131]	new[128]|giv|giv[131]	coref	15-14
13-24	2485-2491	tissue	abstract[128]|object[131]	new[128]|giv[131]	_	_
13-25	2492-2493	,	_	_	_	_
13-26	2494-2507	characterized	_	_	_	_
13-27	2508-2510	by	_	_	_	_
13-28	2511-2516	TNF-α	abstract|abstract[133]	giv|giv[133]	_	_
13-29	2517-2518	,	abstract[133]	giv[133]	_	_
13-30	2519-2524	IFN-γ	abstract[133]|object	giv[133]|new	_	_
13-31	2525-2526	,	abstract[133]	giv[133]	_	_
13-32	2527-2531	IL-6	abstract[133]|abstract	giv[133]|giv	_	_
13-33	2532-2535	and	abstract[133]	giv[133]	_	_
13-34	2536-2549	prostaglandin	abstract[133]|abstract[136]	giv[133]|new[136]	_	_
13-35	2550-2552	E2	abstract[133]|abstract[136]	giv[133]|new[136]	_	_
13-36	2553-2554	(	_	_	_	_
13-37	2555-2559	PGE2	object	new	_	_
13-38	2560-2561	)	_	_	_	_
13-39	2562-2569	release	event	giv	_	_
13-40	2570-2571	,	_	_	_	_
13-41	2572-2577	could	_	_	_	_
13-42	2578-2585	promote	_	_	_	_
13-43	2586-2590	NFκB	abstract|abstract[140]	giv|giv[140]	_	_
13-44	2591-2601	activation	abstract[140]	giv[140]	_	_
13-45	2602-2614	consequently	_	_	_	_
13-46	2615-2623	modulate	_	_	_	_
13-47	2624-2633	dendritic	abstract[142]	giv[142]	_	_
13-48	2634-2638	cell	object|abstract[142]	giv|giv[142]	coref	15-36
13-49	2639-2647	function	abstract[142]	giv[142]	_	_
13-50	2648-2649	,	_	_	_	_
13-51	2650-2654	also	_	_	_	_
13-52	2655-2658	can	_	_	_	_
13-53	2659-2667	activate	_	_	_	_
13-54	2668-2679	neutrophils	abstract	giv	_	_
13-55	2680-2681	.	_	_	_	_

#Text=Controversially , the pro-inflammatory state can inhibit regulatory T cells and NK lymphocytes , and also impair anti-inflammatory defense .
14-1	2682-2697	Controversially	_	_	_	_
14-2	2698-2699	,	_	_	_	_
14-3	2700-2703	the	abstract[144]	new[144]	_	_
14-4	2704-2720	pro-inflammatory	abstract[144]	new[144]	_	_
14-5	2721-2726	state	abstract[144]	new[144]	_	_
14-6	2727-2730	can	_	_	_	_
14-7	2731-2738	inhibit	_	_	_	_
14-8	2739-2749	regulatory	object[146]	giv[146]	coref	15-48[165_146]
14-9	2750-2751	T	person|object[146]	giv|giv[146]	_	_
14-10	2752-2757	cells	object[146]	giv[146]	_	_
14-11	2758-2761	and	object[146]	giv[146]	_	_
14-12	2762-2764	NK	object[146]|abstract	giv[146]|giv	_	_
14-13	2765-2776	lymphocytes	object[146]	giv[146]	_	_
14-14	2777-2778	,	_	_	_	_
14-15	2779-2782	and	_	_	_	_
14-16	2783-2787	also	_	_	_	_
14-17	2788-2794	impair	_	_	_	_
14-18	2795-2812	anti-inflammatory	abstract[148]	new[148]	_	_
14-19	2813-2820	defense	abstract[148]	new[148]	_	_
14-20	2821-2822	.	_	_	_	_

#Text=Taken together , the chronic inflammatory environment promoted by aging can contribute to adipose tissue and skeletal muscle dysfunction and consequently leads to a feedback loop that perpetuates adipose inflammation and redistribution , impairs progenitor cell differentiation and leads to cellular dysfunction and death of adipocytes and neighboring cells such as skeletal muscle cells .
15-1	2823-2828	Taken	_	_	_	_
15-2	2829-2837	together	_	_	_	_
15-3	2838-2839	,	_	_	_	_
15-4	2840-2843	the	abstract[149]	giv[149]	_	_
15-5	2844-2851	chronic	abstract[149]	giv[149]	_	_
15-6	2852-2864	inflammatory	abstract[149]	giv[149]	_	_
15-7	2865-2876	environment	abstract[149]	giv[149]	_	_
15-8	2877-2885	promoted	_	_	_	_
15-9	2886-2888	by	_	_	_	_
15-10	2889-2894	aging	abstract	giv	coref	16-57
15-11	2895-2898	can	_	_	_	_
15-12	2899-2909	contribute	_	_	_	_
15-13	2910-2912	to	_	_	_	_
15-14	2913-2920	adipose	abstract|object[152]	giv|giv[152]	coref	15-29
15-15	2921-2927	tissue	object[152]	giv[152]	_	_
15-16	2928-2931	and	_	_	_	_
15-17	2932-2940	skeletal	abstract[154]	giv[154]	coref	15-41[162_154]
15-18	2941-2947	muscle	object|abstract[154]	new|giv[154]	coref	15-53
15-19	2948-2959	dysfunction	abstract[154]	giv[154]	_	_
15-20	2960-2963	and	_	_	_	_
15-21	2964-2976	consequently	_	_	_	_
15-22	2977-2982	leads	_	_	_	_
15-23	2983-2985	to	_	_	_	_
15-24	2986-2987	a	abstract[156]	new[156]	_	_
15-25	2988-2996	feedback	abstract|abstract[156]	new|new[156]	_	_
15-26	2997-3001	loop	abstract[156]	new[156]	_	_
15-27	3002-3006	that	_	_	_	_
15-28	3007-3018	perpetuates	_	_	_	_
15-29	3019-3026	adipose	abstract|abstract[158]	giv|giv[158]	coref	16-4[168_158]
15-30	3027-3039	inflammation	abstract[158]	giv[158]	_	_
15-31	3040-3043	and	_	_	_	_
15-32	3044-3058	redistribution	abstract	new	_	_
15-33	3059-3060	,	_	_	_	_
15-34	3061-3068	impairs	_	_	_	_
15-35	3069-3079	progenitor	abstract[161]	giv[161]	_	_
15-36	3080-3084	cell	place|abstract[161]	giv|giv[161]	_	_
15-37	3085-3100	differentiation	abstract[161]	giv[161]	_	_
15-38	3101-3104	and	_	_	_	_
15-39	3105-3110	leads	_	_	_	_
15-40	3111-3113	to	_	_	_	_
15-41	3114-3122	cellular	abstract[162]	giv[162]	_	_
15-42	3123-3134	dysfunction	abstract[162]	giv[162]	_	_
15-43	3135-3138	and	_	_	_	_
15-44	3139-3144	death	event[163]	new[163]	_	_
15-45	3145-3147	of	event[163]	new[163]	_	_
15-46	3148-3158	adipocytes	event[163]|object	new[163]|giv	_	_
15-47	3159-3162	and	_	_	_	_
15-48	3163-3174	neighboring	object[165]	giv[165]	ana	16-46[0_165]
15-49	3175-3180	cells	object[165]	giv[165]	_	_
15-50	3181-3185	such	object[165]	giv[165]	_	_
15-51	3186-3188	as	object[165]	giv[165]	_	_
15-52	3189-3197	skeletal	object[165]	giv[165]	_	_
15-53	3198-3204	muscle	object[165]|object	giv[165]|giv	coref	16-6[169_0]
15-54	3205-3210	cells	object[165]	giv[165]	_	_
15-55	3211-3212	.	_	_	_	_

#Text=The effects of inflammation on skeletal muscle is also related to the effects of inflammatory mediators on muscle protein metabolism ( muscle protein breakdown and synthesis ) ; however , way in which the inflammatory factors can induce muscle wasting and the extent to which they do so remains a largely unexplored area of research in aging .
16-1	3213-3216	The	abstract[167]	new[167]	_	_
16-2	3217-3224	effects	abstract[167]	new[167]	_	_
16-3	3225-3227	of	abstract[167]	new[167]	_	_
16-4	3228-3240	inflammation	abstract[167]|abstract[168]	new[167]|giv[168]	_	_
16-5	3241-3243	on	abstract[167]|abstract[168]	new[167]|giv[168]	_	_
16-6	3244-3252	skeletal	abstract[167]|abstract[168]|object[169]	new[167]|giv[168]|giv[169]	coref	16-18[0_169]
16-7	3253-3259	muscle	abstract[167]|abstract[168]|object[169]	new[167]|giv[168]|giv[169]	_	_
16-8	3260-3262	is	_	_	_	_
16-9	3263-3267	also	_	_	_	_
16-10	3268-3275	related	_	_	_	_
16-11	3276-3278	to	_	_	_	_
16-12	3279-3282	the	abstract[170]	new[170]	_	_
16-13	3283-3290	effects	abstract[170]	new[170]	_	_
16-14	3291-3293	of	abstract[170]	new[170]	_	_
16-15	3294-3306	inflammatory	abstract[170]|person[171]	new[170]|new[171]	_	_
16-16	3307-3316	mediators	abstract[170]|person[171]	new[170]|new[171]	_	_
16-17	3317-3319	on	abstract[170]|person[171]	new[170]|new[171]	_	_
16-18	3320-3326	muscle	abstract[170]|person[171]|object|abstract[174]	new[170]|new[171]|giv|new[174]	coref	16-22
16-19	3327-3334	protein	abstract[170]|person[171]|substance|abstract[174]	new[170]|new[171]|giv|new[174]	coref	16-23
16-20	3335-3345	metabolism	abstract[170]|person[171]|abstract[174]	new[170]|new[171]|new[174]	_	_
16-21	3346-3347	(	_	_	_	_
16-22	3348-3354	muscle	object	giv	coref	16-39
16-23	3355-3362	protein	substance	giv	_	_
16-24	3363-3372	breakdown	_	_	_	_
16-25	3373-3376	and	_	_	_	_
16-26	3377-3386	synthesis	_	_	_	_
16-27	3387-3388	)	_	_	_	_
16-28	3389-3390	;	_	_	_	_
16-29	3391-3398	however	abstract[177]	new[177]	_	_
16-30	3399-3400	,	abstract[177]	new[177]	_	_
16-31	3401-3404	way	abstract[177]	new[177]	_	_
16-32	3405-3407	in	_	_	_	_
16-33	3408-3413	which	_	_	_	_
16-34	3414-3417	the	abstract[178]	giv[178]	_	_
16-35	3418-3430	inflammatory	abstract[178]	giv[178]	_	_
16-36	3431-3438	factors	abstract[178]	giv[178]	_	_
16-37	3439-3442	can	_	_	_	_
16-38	3443-3449	induce	_	_	_	_
16-39	3450-3456	muscle	object	giv	_	_
16-40	3457-3464	wasting	_	_	_	_
16-41	3465-3468	and	_	_	_	_
16-42	3469-3472	the	abstract[180]	new[180]	_	_
16-43	3473-3479	extent	abstract[180]	new[180]	_	_
16-44	3480-3482	to	_	_	_	_
16-45	3483-3488	which	_	_	_	_
16-46	3489-3493	they	object	giv	_	_
16-47	3494-3496	do	_	_	_	_
16-48	3497-3499	so	_	_	_	_
16-49	3500-3507	remains	_	_	_	_
16-50	3508-3509	a	abstract[182]	new[182]	_	_
16-51	3510-3517	largely	abstract[182]	new[182]	_	_
16-52	3518-3528	unexplored	abstract[182]	new[182]	_	_
16-53	3529-3533	area	abstract[182]	new[182]	_	_
16-54	3534-3536	of	abstract[182]	new[182]	_	_
16-55	3537-3545	research	abstract[182]|abstract[183]	new[182]|new[183]	_	_
16-56	3546-3548	in	abstract[182]|abstract[183]	new[182]|new[183]	_	_
16-57	3549-3554	aging	abstract[182]|abstract[183]|abstract	new[182]|new[183]|giv	_	_
16-58	3555-3556	.	_	_	_	_
